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ABSTRACT Conformational diseases are associated with the conversion of normal proteins 
into aggregation-prone toxic conformers with structures similar to that of β-amyloid. Spatial 
distribution of amyloid-like proteins into intracellular quality control centers can be beneficial, 
but cellular mechanisms for protective aggregation remain unclear. We used a high-copy sup-
pressor screen in yeast to identify roles for the Hsp70 system in spatial organization of toxic 
polyglutamine-expanded Huntingtin (Huntingtin with 103Q glutamine stretch [Htt103Q]) 
into benign assemblies. Under toxic conditions, Htt103Q accumulates in unassembled states 
and speckled cytosolic foci. Subtle modulation of Sti1 activity reciprocally affects Htt toxicity 
and the packaging of Htt103Q into foci. Loss of Sti1 exacerbates Htt toxicity and hinders foci 
formation, whereas elevation of Sti1 suppresses Htt toxicity while organizing small Htt103Q 
foci into larger assemblies. Sti1 also suppresses cytotoxicity of the glutamine-rich yeast prion 
[RNQ+] while reorganizing speckled Rnq1–monomeric red fluorescent protein into distinct 
foci. Sti1-inducible foci are perinuclear and contain proteins that are bound by the amyloid 
indicator dye thioflavin-T. Sti1 is an Hsp70 cochaperone that regulates the spatial organiza-
tion of amyloid-like proteins in the cytosol and thereby buffers proteotoxicity caused by 
amyloid-like proteins.
INTRODUCTION
Protein conformational diseases represent a collection of disorders 
in which structurally diverse proteins are converted into a common 
cytotoxic conformational state that has features of β-amyloid (Carrell 
and Lomas, 1997). A large number of normal proteins are converted 
to an amyloid-like state that is rich in β-structure, detergent insolu-
ble, and binds indicator dyes such as thioflavin-T (Chiti and Dobson, 
2006). β-Amyloid is deposited in extracellular plaques in the brains 
of Alzheimer’s patients (Chiti and Dobson, 2006; Haass and Selkoe, 
2007; Treusch et al., 2009), and there are also numerous instances 
in which protein conformational disease is associated with intracel-
lular accumulation of amyloid-like assemblies (Carrell and Lomas, 
1997). Flux of proteins through the amyloid assembly pathway is 
associated with disease, but whether the amyloid-like aggregates 
themselves or small oligomers of converted proteins are toxic is 
debatable (Bucciantini et al., 2004; Cohen et al., 2006; Wolfe and 
Cyr, 2011). There is mounting evidence that molecular chaperones 
facilitate the packaging of toxic protein species into protein-han-
dling depots to suppress proteotoxicity (Muchowski and Wacker, 
2005; Douglas et al., 2008). Yet the cellular mechanisms for mole-
cular chaperone function in protective protein aggregation remain 
unclear.
Hsp70 functions with specialized cochaperones to suppress pro-
tein aggregation, refold clients, and promote protein degradation 
(Cyr et al., 1994, 2002; Meacham et al., 2001; Tyedmers et al., 
2010a). Hsp70 binds extended regions of polypeptide chains in an 
ATP-dependent reaction cycle that is regulated by Hsp40 (Liberek 
et al., 1991; Cyr et al., 1992; Langer et al., 1992). Hsp40 serves as a 
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the mechanism for spatial segregation of protein handling centers is 
a mystery.
Although flux through protein aggregation pathways is associ-
ated with cell death, chaperone-dependent sequestration of 
amyloid-like proteins into protein-handling centers correlates with 
suppression of proteotoxicity (Cohen et al., 2006; Douglas et al., 
2008; Summers et al., 2009; Treusch et al., 2009). In yeast models, 
overexpression of the yeast prion protein Rnq1 is toxic, but only if 
preexisting [RNQ+] prions are present to seed its conversion to an 
amyloid-like conformation (Sondheimer and Lindquist, 2000; 
Derkatch et al., 2001; Douglas et al., 2008). The Hsp70, Ssa1, coop-
erates with the Hsp40, Sis1, to increase the efficiency by which 
seeded forms of Rnq1 assemble into amyloid-like [RNQ+] prions 
and thereby suppress proteotoxicity (Douglas et al., 2008). Of inter-
est, a fragment of Huntingtin (Htt) similar to those found in inclu-
sions from Huntington’s disease brains (Htt with 103Q glutamine 
stretch [Htt103Q]), is toxic when expressed ectopically in yeast, but 
only if [RNQ+] prions are present (Meriin et al., 2002). In yeast, the 
aggregation state of Htt103Q and its toxicity are inversely corre-
lated with very tight, detergent-insoluble aggregates being benign 
and loose, detergent-soluble aggregates being toxic (Duennwald 
et al., 2006). Aggregation and toxicity of Htt103Q are influenced 
by its subcellular environment and also by the sequences of amino 
acids that flank its polyglutamine (polyQ) stretch (Dehay and 
Bertolotti, 2006; Duennwald et al., 2006; Douglas et al., 2009). 
Forms of Htt103Q that contain the polyproline region that follows 
the polyQ domain in full-length Htt are benign due to their seques-
tration into the aggresome in a process that requires the ringed 
molecular chaperone p97 (Wang et al., 2009). Forms of Htt103Q 
that lack the polyproline region are toxic, as they accumulate in 
loose aggregates that are distributed throughout the cytosol in 
speckled foci and tight aggregates that accumulate in the IPOD 
(Kaganovich et al., 2008; Douglas et al., 2009). Thus studies on pro-
teotoxicity of Htt103Q and Rnq1 in yeast provide an excellent model 
system in which to uncover mechanisms for Hsp70 function in pro-
tein detoxification through protective protein aggregation.
Here we uncover a role for the cochaperone Sti1 in orchestrating 
spatial organization of Htt103Q and Rnq1 into benign amyloid-like 
assemblies. We use the toxic form of Htt103Q lacking the proline-
rich region and screen for proteins that suppress proteotoxicity by 
facilitating its aggregation. Sti1 cooperates with the Hsp70 system 
to control the spatial organization of amyloid-like protein assem-
blies, thereby suppressing proteotoxicity.
RESULTS
The Hsp70/Hsp90 cochaperone Sti1 suppresses 
Htt103Q toxicity
To identify cellular factors that defend against proteotoxicity, we 
carried out a high-copy screen in Saccharomyces cerevisiae to dis-
cover proteins that suppressed Htt103Q toxicity. A construct en-
coding the first 17 amino acids of the Htt gene followed by 103 
glutamines and a green fluorescent protein (GFP) moiety (Htt103Q) 
was integrated into a W303α strain under control of the galactose 
promoter. Htt103Q expression caused a growth defect in a glu-
tamine length–dependent manner (Meriin et al., 2002; Duennwald 
et al., 2006), and differential sensitivity to Htt103Q was exhibited 
by individual strains (Figure 1A). The yeast Hsp70/Hsp90 cochap-
erone Sti1 (Nicolet and Craig, 1989) was identified as a high-copy 
suppressor of the severe Htt103Q-dependent growth defect (see 
Materials and Methods for details of the suppressor screen). 
Expression of the TPR family cochaperones Cns1 (Dolinski et al., 
1998) and Sgt2 (Kordes et al., 1998) did not suppress Htt103Q 
substrate selector and helps stabilize Hsp70:polypeptide complexes 
by converting Hsp70-ATP to Hsp70-ADP. Substrate release from 
Hsp70 is regulated by nucleotide exchange factors and tetratrico-
peptide repeat (TPR) cochaperones (Scheufler et al., 2000; Steel 
et al., 2004; Shaner et al., 2005). TPR cochaperones contain a TPR 
repeat, which serves as an Hsp70/Hsp90 interaction domain that 
recognizes a conserved C-terminal EEVD motif (Scheufler et al., 
2000), and specialized functional domains that dictate the fate of 
chaperone-bound clients. Sti1 is a TRP-repeat cochaperone whose 
mammalian homologue is HOP, which contains three separate TPR 
domains that serve to bring Hsp70 and Hsp90 together in com-
plexes and act sequentially on clients (Hernandez et al., 2002). Sti1 
also functions with Hsp70 and Hsp40 to modulate the biogenesis 
and function of prions in yeast and humans (Jones et al., 2004; Reidy 
and Masison, 2010; Roffe et al., 2010). CyP40 contains a cis-trans-
prolyl-isomerase domain that facilitates conformational maturation 
of late-stage protein-folding intermediates (Chen et al., 1998); CHIP 
is a ubiquitin ligase that regulates the heat stress response (Dai 
et al., 2003; Qian et al., 2006) and targets misfolded proteins for 
proteasomal degradation (Jiang et al., 2001; Meacham et al., 2001). 
Thus TPR-repeat cochaperones of Hsp70/Hsp90 act downstream of 
Hsp40s and participate in multiple aspects of protein homeostasis.
In protein aggregates, hydrophobic surfaces that would be rec-
ognized by components of the Hsp70 system are buried, so they 
escape recognition by protein quality control machines. Thus ag-
gregates are inefficiently cleared from cells and cause cytotoxicity 
by damaging cell membranes, altering the conformation of other 
proteins, and sequestering essential cellular proteins (Haass and 
Selkoe, 2007; Last et al., 2011; Olzscha et al., 2011). Aberrant pro-
teins that are not initially cleared from the cytosol can be segregated 
into distinct cytosolic foci, observed in both yeast and mammalian 
systems, which appear to store oligomers and aggregates until con-
ditions favor refolding or degradation (Johnston et al., 1998; 
Kaganovich et al., 2008; Wang et al., 2009; Tyedmers et al., 2010b; 
Specht et al., 2011; Malinovska et al., 2012; Weisberg et al., 2012; 
Shiber et al., 2013; Summers et al., 2013). Remarkably, detergent-
soluble and amyloid-like protein conformers are segregated into 
different protein-handling depots, and this process is influenced by 
components in the Hsp70 system (Douglas et al., 2008, 2009; 
Malinovska et al., 2012; Summers et al., 2013). Amyloid-like and 
detergent-insoluble protein assemblies accumulate in perinuclear 
aggresomes (Johnston et al., 1998; Wang et al., 2009) and insoluble 
protein deposits (IPODs), which are located in the cell periphery 
(Kaganovich et al., 2008; Tyedmers et al., 2010b). Protein oligomers 
and aggregates that are soluble in detergents accumulate in the 
spatially distinct juxtanuclear quality control (JUNQ; Kaganovich 
et al., 2008; Weisberg et al., 2012) and peripheral compartments 
(Specht et al., 2011). Ubiquitinated proteins that evade the protea-
some and terminally misfolded proteins that escape recognition by 
protein quality control (PQC) E3 ligases are swept into the JUNQ 
(Kaganovich et al., 2008). Proteins in the JUNQ can be solubilized 
and degraded by the proteasome in a pathway that involves the 
PQC E3 ligase Ubr1 (Summers et al., 2013). The peripheral compart-
ment contains Hsp42 and holds proteins in a folding-competent 
state (Specht et al., 2011). The IPOD may function in disaggregation 
of detergent-insoluble protein aggregates (Tyedmers et al., 2010b), 
whereas the peripheral compartment and JUNQ aid in refolding 
(Specht et al., 2011) and degradation (Kaganovich et al., 2008) of 
detergent-soluble protein assemblies, respectively. The aggresome 
resembles an inclusion body and may represent a long-term storage 
site for aberrant proteins (Johnston et al., 1998; Wang et al., 2009). 
Thus cells have the capacity to sequester toxic protein species, but 
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So, loss of Sti1 function reduces the capacity of cells to tolerate 
expression of Htt103Q.
Elevation of Sti1 caused the redistribution of Htt103Q from a 
mixture of diffuse material and foci that are dispersed throughout 
the cytosol into several distinct large foci that were often found in 
close proximity to the nucleus (Figure 1, B and C). Conversely, 
toxicity (Supplemental Figure S1A), indicating that this activity is 
not a characteristic of TPR proteins in general. Of importance, de-
letion of STI1 caused Htt103Q to become toxic in a strain in which 
it was normally benign (Figure 1A, right). Parallel growth assays 
using wild-type and ΔSti1 Htt25Q strains demonstrate that dele-
tion of STI1 does not reduce growth on galactose (Figure 1A, left). 
FIGURE 1: Sti1 suppresses Htt103Q toxicity and reorganizes Htt103Q-GFP foci. (A) Effect of Sti1 on Htt103Q growth 
defect as monitored by cell growth assay plated in fivefold dilutions. Htt103Q and Htt103Q-NoTox are two integration 
strains with similar Htt expression that differ in severity of the growth defect. (B, C) Effect of Sti1 on organization of 
Htt103Q-GFP foci. Cells expressing Htt103Q-GFP for 4 h from the GAL1 promoter were fixed as indicated in Materials 
and Methods. Quantitation indicates 150–300 individual cells counted from different experiments using ImageJ. 
(D) Expression levels of Htt as detected by Western blot analysis of lysates taken from cultures grown from strains in A. 
Graph depicts quantitation of Sti1 overexpression compared with endogenous Sti1 (n = 6). (E) Expression level and 
localization of Htt103Q-GFP as in B and D. Here Htt103Q was expressed from a CUP1 promoter induced with 500 μM 
CuSO4 for 4 h. (F) Influence of Sti1 on organization of mCitrine-luciferase during heat shock. Cells were imaged live 
during growth at 30°C and then again after a shift to 42°C for 20 min. (G) Colocalization of Htt103Q-GFP and Sti1-mRFP. 
White arrows indicate colocalization. Nuclei were visualized using DAPI staining. Lysates for Western blot analysis came 
from cells grown under the same conditions used for fluorescence microscopy.
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formation and this is beneficial to the cell, so there is an inverse re-
lationship between Htt103Q aggregation and toxicity that is modu-
lated by Sti1.
Sti1 interacts with high–molecular weight forms of Htt103Q
To understand the mechanism for Sti1 action, we asked whether Sti1 
interacts with low–molecular weight Htt103Q or high–molecular 
weight oligomeric assemblies via gel filtration chromatography. Cell 
lysates prepared by homogenizing spheroplasts in the absence of 
detergent were immediately applied to a Sephacryl S-200 column. 
Proteins in every third fraction were resolved on an SDS–PAGE gel 
and probed by Western blot for levels of Htt103Q and Sti1 (Figure 
2, A–C). A portion of high–molecular weight, SDS-resistant Htt103Q 
is retained at the stacking front of the gel (Douglas et al., 2009), so 
both the stacking and running gel sections are shown and quanti-
tated. Htt expression was similar in the presence of endogenous 
and overexpressed Sti1 (Figure 1C). Under all conditions, a pool of 
Sti1 migrated as a low–molecular weight form (Figure 2A); Sti1 is 
proposed to function as a dimer (Prodromou et al., 1999) as well as 
a monomer and is also bound to Hsp70/Hsp90 (Li et al., 2011). The 
separating power of gel filtration chromatography is insufficient to 
discern between these different low–molecular weight species of 
Sti1. Yet the mobility of endogenous low–molecular weight Sti1 is 
shifted to a high–molecular weight fraction in the presence of 
Htt103Q, whereas low–molecular weight Htt103Q did not comi-
grate with low–molecular weight Sti1 (Figure 2A, top/control). Of 
importance, endogenous Sti1 did not migrate in a high–molecular 
weight fraction when non–aggregation-prone Htt25Q was ex-
pressed (Figure 2A, bottom). On overexpression of Sti1, the high–
molecular weight pools of Sti1 and Htt103Q both increased propor-
tionally (Figure 2, A, top/+Sti1, and C), yet this was not observed 
when Sti1 levels were elevated in the presence of Htt25Q (Figure 
2A, bottom/+Sti1). Sti1 was also present in immune complexes 
when high–molecular weight Htt103Q was precipitated from col-
umn fraction 12 (Figure 2B). This interaction was specific because 
there was no Sti1 signal detected in the absence of Htt103Q (Figure 
2B). While reorganizing foci and suppressing toxicity, Sti1 appears to 
interact with high–molecular weight forms of Htt103Q.
Under conditions in which Sti1 increases pools of high–molecular 
weight Htt103Q, an increase in the pool size of low–molecular 
weight Htt103Q also occurs (Figure 2A). We believe that this hap-
pens because the higher–molecular weight pools of Htt103Q are 
elevated, and assembled Htt103Q is more stable than unassembled 
forms. Amyloid-like assemblies are dynamic, so a pool of Htt103Q 
monomers should be in equilibrium with the higher–molecular 
weight species. Thus the corresponding increase in low–molecular 
weight as well as high–molecular weight forms of Htt103Q is not 
unexpected. We speculate that since more low–molecular weight 
Htt103Q is detected when Sti1 is overexpressesed and growth de-
fects are suppressed, the conformer of low–molecular weight 
Htt103Q detected is nontoxic. Sti1 appears to increase accumula-
tion of a benign high–molecular weight form of Htt103Q and may 
also hinder conversion of monomeric Htt103Q to an aberrant toxic 
conformer.
Sti1 directs amyloidogenic proteins to a perinuclear location
Htt103Q is toxic to yeast upon undergoing a conformational change 
driven by interaction with the [RNQ+] prion (Derkatch et al., 2001; 
Meriin et al., 2002). [RNQ+] prion biogenesis and toxicity are modu-
lated by Hsp70 and Hsp40 (Sondheimer et al., 2001; Aron et al., 
2007; Douglas et al., 2008; Tipton et al., 2008), and weak variants 
of the prion [PSI+] are eliminated from yeast by elevation of Sti1 
deletion of STI1 greatly reduced Htt103Q punctae formation, with 
the majority of Htt dispersed in a diffuse cytosolic pattern (Figure 1, 
B and C). Sti1 overexpression had no effect upon Htt103Q levels, 
yet deletion reduced expression (Figure 1D), likely due to delayed 
induction from the galactose promoter (Floer et al., 2008). Deletion 
of STI1 clearly sensitizes the cell to Htt103Q because even though 
there was reduced Htt103Q expression, growth defects caused by 
Htt103Q were exacerbated.
Sti1 may suppress Htt103Q toxicity by organizing it into foci; 
however, fewer foci may be observed in the ΔSti1 strain because 
there is less Htt103Q being expressed. To rule out this possibility, 
Htt103Q-GFP localization was examined when expressed to equiva-
lent levels via copper-inducible promoter in wild-type and ΔSti1 
strains (Figure 1E). Again Sti1 was required for efficient organization 
of Htt103Q into foci. We also examined the influence of Sti1 expres-
sion upon temporal aspects of Htt103Q foci accumulation. Over a 
4-h time course, Sti1 accelerated Htt103Q foci formation while re-
ducing number of foci per cell (Supplemental Figure S1B). Cyclo-
heximide chase experiments demonstrate that once formed, the 
Sti1-dependent foci containing Htt103Q were stable for at least 5 h 
(Supplemental Figure S1C). These data provide a correlation be-
tween Sti1 action in suppression of Htt toxicity and packaging of 
Htt103Q into perinuclear foci.
Does Sti1 act only on Htt103Q, or can it also modulate the orga-
nization of other cytosolic protein aggregates? To answer this ques-
tion, we used mCitrine-tagged luciferase, an Hsp70 client that ag-
gregates during heat stress (Specht et al., 2011). At 30°C, 
mCitrine-luciferase is diffuse throughout the cytosol and was not 
affected by Sti1 overexpression (Figure 1F, top). During thermal 
stress at 42°C for 20 min, luciferase accumulated in numerous ag-
gregates throughout the cytosol (Figure 1F). Neither elevation nor 
deletion of STI1 changed the appearance of the luciferase aggre-
gates (Figure 1F, bottom). Thus, since Sti1 does not suppress ag-
gregation of heat-damaged luciferase or organize aggregated lu-
ciferase into foci, it may act specifically on amyloid-like forms of 
Htt103Q.
The TPR cochaperone CHIP inhibits Hsp70 function in protein 
folding (Jiang et al., 2001), so it is possible that Sti1 affects Htt103Q 
assembly into foci by similarly interfering with Hsp70. This is unlikely 
because Sti1 overexpression does not cause mCitrine-luciferase to 
aggregate (Figure 1F). In addition, Sti1 is implicated as an indepen-
dent activator of Ssa1 ATPase activity and is able to stimulate Ydj1-
dependent refolding of luciferase by Hsp70 (Wegele et al., 2003, 
2006). Nevertheless, we examined in the effect of purified Sti1 on 
the ability of Ssa1 and Sis1 to refold denatured luciferase. When Sti1 
was added at a fourfold molar excess over Ssa1 and Sis1 it had little 
detectable effect on luciferase refolding (Supplemental Figure S1, D 
and E). In contrast, the TPR-repeat protein CHIP, which has antichap-
erone functions, inhibited Ssa1- and Sis1-dependent refolding of 
luciferase. Thus, when paired with Ydj1, Sti1 can stimulate luciferase 
refolding, but under the conditions used here it does not stimulate 
the refolding activity of Sis1 and Ssa1. In contrast to CHIP, Sti1 is a 
positive regulator of Hsp70 function and appears capable of en-
hancing interactions between Ssa1 and Htt103Q (Wegele et al., 
2003) and may thereby affect spatial quality control.
If Sti1 has a direct effect on Htt103Q, it should be present with 
Htt103Q foci. When expressed alone, Sti1 tagged with a mono-
meric red fluorescent protein (mRFP) exhibited a diffuse localization 
pattern in the cytosol (Figure 1G). When coexpressed with Htt103Q, 
it redistributed the polyQ protein into distinct punctae, and Sti1-
mRFP was indeed concentrated in foci with Htt103Q (Figure 1G, 
arrows). These data demonstrate that Sti1 promotes Htt103Q foci 
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speckled throughout the cytosol, but upon overexpression of Sti1, 
Rnq1-mRFP became localized to one or two distinct juxtanuclear 
foci (Figure 3C). In contrast to what is observed with Htt103Q-GFP, 
speckled Rnq1-mRFP foci were still detected in a ΔSti1 strain, indi-
cating that this strain remains in the [RNQ+] prion state (Figure 3C, 
ΔSti1). Sti1 is not required for maintenance of [RNQ+] prions, and 
Sti1 overexpression does not eliminate [RNQ+] prions. Instead, 
activity (Kryndushkin et al., 2002). Thus we evaluated the effect of 
Sti1 on [RNQ+] prion toxicity and subcellular organization. As with 
Htt103Q, an increase in Sti1 suppressed the toxicity associated with 
Rnq1 overexpression (Figure 3A). Under the conditions used, Rnq1 
expression is highly toxic, and so deletion of STI1 led to only mod-
est increase in growth defects caused by Rnq1 overexpression 
(Figure 3B). At endogenous levels of Sti1, Rnq1-mRFP foci were 
FIGURE 2: Sti1 cofractionates with high–molecular weight forms of Htt103Q. (A) Migration of indicated forms of Htt 
with Sti1 on Sephacryl S200 gel filtration column at endogenous (control) or overexpressed Sti1 levels as detected by 
Western blot. (B) Detection of Sti1 in immune precipitates with FLAG-Htt103Q-GFP. Immunoprecipitation was 
performed with anti-FLAG conjugated beads from aliquots of fraction 12 containing both Htt103Q and Sti1 or from 
fraction 28 containing only Sti1 as a background control. The immunoprecipitation was carried out using the column 
sample with elevated levels of Sti1, and precipitates were analyzed by Western blot. (C) Quantitation of total Htt103Q 
in column fractions that was detected in both the stacking and running gel plotted vs. the fraction number. The total 
signal in the gel and the quantitation shown in the graph reflect each other. Nondenaturing lysates were prepared as 
described in Materials and Methods, and equivalent amounts of total protein per sample were applied to the S200 
column.
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we asked whether Sti1-inducible foci stain positive for the amyloid-
specific dye thioflavin-T (Chiti and Dobson, 2006). Rnq1-mRFP was 
used as a tool instead of Htt103Q-GFP because, upon binding amy-
loid, thioflavin-T emission is enhanced to a wavelength in the excita-
tion range of GFP (LeVine, 1993). [RNQ+] prions have features of 
amyloid-like protein species, as they bind thioflavin-T, whereas the 
dye does not bind to amorphous aggregates of Rnq1 that accumu-
late in an [rnq-] strain (Douglas et al., 2008). Speckled Rnq1-mRFP 
foci in both the cell periphery and perinuclear locations were posi-
tive for thioflavin-T staining. Perinuclear Rnq1-mRFP foci whose for-
mation is induced by Sti1 are also thioflavin-T positive (Figure 4E).
To ascertain whether Htt103Q is also present in foci with amy-
loid-like [RNQ+] prions, we asked whether they colocalize with each 
other in the presence and absence of Sti1 overexpression (Figure 
4F). When Htt103Q-GFP and Rnq1-mRFP were coexpressed, a 
mixed population of speckled foci was detected, with ∼20% of foci 
containing both proteins (Figure 4F, inset and arrows). Sti1 elevation 
resulted in redistribution of most of the Htt103Q and Rnq1 to one or 
two larger perinuclear foci that contain both proteins (Figure 4F).
Owing to the colocalization of Htt103Q and Rnq1 in foci that 
contain amyloid-like proteins, we asked whether Sti1 is necessary for 
these proteins to interact. To answer this question, we took advan-
tage of the fact that addition of a nuclear localization signal (NLS) to 
Rnq1 directs [RNQ+] prions to the nucleus and Htt103Q follows 
(Douglas et al., 2009). Thus, if Sti1 is required for interaction be-
tween Htt103Q and Rnq1, STI1 deletion of would prevent this relo-
calization. However, Rnq1-NLS still redistributed Htt103Q to the 
nucleus in both the presence and absence of Sti1 (Supplemental 
Figure S2A). Thus Sti1 promotes accumulation of Htt103Q and foci 
that contain amyloid-like species of Rnq1 but does not appear to be 
necessary for Rnq1 and Htt to interact. Instead, Sti1 may control the 
spatial organization of amyloid-like protein-handling centers.
Sti1-inducible foci colocalize with markers for cytosolic 
protein-handling depots
Sti1-inducible foci (StiF) are perinuclear and contain amyloid-like 
material, yet it is unclear whether they have features of protein-han-
dling depots such as the IPOD and JUNQ. To characterize the StiF 
in more detail, we determined whether these foci contain PQC ma-
chinery that would help protect cells from proteotoxic stress. Under 
normal conditions, Hsp104 and Hsp42 were not detected in the 
speckled foci that contain Htt103Q-GFP (Figure 5, A and B), but 
Hsp104 and Hsp42 were present in StiF. Sti1 expression caused 
Hsp104 to become concentrated in Stif because its signal intensity 
in the cytosol versus the Stif has a 1:1.5 ratio. Although Hsp42 did 
colocalize with Htt103Q, the signal for Hsp42 in foci and cytosol had 
a 1:1 ratio, so it is difficult to judge whether the colocalization ob-
served is due to overlap in staining or concentration of Hsp42 to the 
StiF.
Because the StiF is an Hsp104-positive inclusion, we next deter-
mined whether StiF formation is affected by modulation of Hsp104 
activity. Here we treated cells containing endogenous or overex-
pressed Sti1 with guanidinium hydrochloride (GndHCl) for 4 h to 
inhibit Hsp104 (Ferreira et al., 2001; Jung and Masison, 2001) and 
monitored the effect this had on organization of Rnq1-mRFP into 
foci. To determine the nature of the foci observed, we used strains 
containing a GFP-tagged version of Hsp42 or Spc42, a spindle pole 
body component that marks the aggresome (Johnston et al., 1998). 
Hsp104 inhibition condensed most of the Rnq1-mRFP material to 
one peripherally localized puncta, which colocalized with Hsp42 but 
not with Spc42 (Figure 5, C and D). Foci formed during Sti1 overex-
pression in the untreated samples did not colocalize with Spc42 
suppression of Rnq1 and Htt103Q toxicity by Sti1 is associated with 
organization of multiple punctae containing these proteins into one 
or two distinct perinuclear foci.
We next sought to determine what conformational state of Rnq1 
and Htt103Q is favored under conditions in which Sti1 suppresses 
their proteotoxicty. Sti1 increased accumulation of oligomeric SDS-
resistant forms of Rnq1 and Htt103Q by more than twofold (Figure 
4, A–C). Deletion of STI1 reduced Htt103Q SDS-resistant material 
by >50%, but there was little effect on Rnq1 (Figure 4, A–C). Sti1 
appears to act on the oligomeric assemblies of Htt103Q and Rnq1 
that only form in [RNQ+] prion strains because its overexpression 
has no effect on localization of Htt103Q or Rnq1 in [rnq-] strains 
(Figure 4D).
Conversion to an SDS-resistant oligomer is a characteristic of 
amyloid, so Sti1 appears to target amyloid-like forms of proteins to 
perinuclear foci. To gain experimental support for this conclusion, 
FIGURE 3: Sti1 suppresses Rnq1 toxicity and reorganizes Rnq1-mRFP 
foci. (A, B) Effect of Sti1 on the growth defect caused by Rnq1-mRFP 
overexpression as monitored by cell growth assay plated in fivefold 
dilutions. Toxicity assay was plated on synthetic media containing 2% 
glucose and 500 μM CuSO4. (C) Effect of Sti1 on organization of 
Rnq1-mRFP foci. Expression levels of Rnq1-mRFP were detected by 
Western blot analysis under conditions identical to those used for 
fluorescence microscopy and described in Materials and Methods.
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FIGURE 4: Sti1 modulates assembly of amyloidogenic substrates. (A–C) The effect of Sti1 on SDS-resistant Htt103Q-
GFP or Rnq1-mRFP. SDS-resistant material was measured by SDD-AGE. (A, B) Representative images of quantitation 
shown in C (values represent means ± SE, n ≥ 3, *p < 0.05, **p < 0.005). (B) Inability of Sti1 to reorganize Htt103Q-
GFP or Rnq1-mRFP to foci in an [rnq-] background. (C) Staining of Rnq1-mRFP foci with the amyloid indicator dye 
thioflavin-T, as well as with DAPI to indicate nuclei. (D) Colocalization of Htt103-GFP and Rnq1-mRFP during Sti1 
overexpression. White arrows indicate colocalization. Insets represent the same punctae indicated with white arrows 
in the main images.
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of GndHCl prevents Rnq1-mRFP from accumulating in peripheral 
foci with Hsp42-GFP and instead promotes its accumulation in the 
StiF.
These data demonstrate that organization of Rnq1 in speckled 
foci is highly sensitive to modulation of Hsp104 and Hsp70 system 
activity. Impairment of Hsp104 leads Rnq1-mRFP to accumulate in a 
single cytosolic puncta instead of speckled foci. The effects of Sti1 
on Rnq1-mRFP foci resemble those of Hsp104, except that Sti1 pro-
motes accumulation of amyloid-like proteins in StiF rather than a 
peripheral puncta. The StiF is a perinuclear quality control depot 
that contains Sti1, Hsp104, and amyloid-like proteins. It appears to 
be distinct from the aggresome, as it does not form at the spindle 
(Figure 5C). Furthermore, Htt103Q-GFP containing the proline-rich 
region is targeted in a p97-dependent manner to aggresomes 
(Wang et al., 2009), and deletion of STI1 has no effect on aggrega-
tion of Htt103Q-Pro (Supplemental Figure S2B). Therefore Sti1 is 
not promoting the accumulation of Htt103Q in the yeast 
aggresome.
Strikingly, Sti1 appears to prevent accumulation of Rnq1-mRFP in 
the IPOD and by promoting its accumulation in StiF. Rnq1 is consid-
ered to be an IPOD marker (Kaganovich et al., 2008; Tyedmers 
et al., 2010b), and the single Rnq1-mRFP and Hsp42-GFP–contain-
ing peripheral foci detected when Hsp104 is inhibited for 2 h appear 
to be the IPOD (Figure 5, C and D). Elevation of Sti1 in the presence 
FIGURE 5: Sti1-inducible foci colocalize with markers for cytosolic protein-handling depots. (A, B) Localization 
of endogenous (A) Hsp104 or (B) Hsp42 as monitored by immunofluorescence using Htt103Q as a StiF marker. 
(C, D) Effect of Hsp104 inhibition on Rnq1-mRFP localization at the StiF. Fluorescence microscopy was carried out in 
strains with (C) Spc42 or (D) Hsp42 tagged at the endogenous locus with GFP. Rnq1-mRFP was induced with 50 μM 
CuSO4, and Hsp104 was inhibited with 3 mM GndHCl for 2 h before cells were fixed. Nuclei were visualized using DAPI 
staining. Dotted lines indicate the outline of the cell.
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speckled foci and Sis1-GFP was distributed between the cytosol 
and nucleus (Figure 7C; Douglas et al., 2009). On elevation of Sti1, 
the localization pattern of Sis1 changed dramatically, and a large 
pool of it was concentrated in the StiF with Rnq1-mRFP (Figure 7C). 
Data presented in Figures 5–7 suggest that Sti1 helps suppress pro-
teotoxicity via stabilization of complexes between Hsp70, Sis1, and 
amyloid-like protein assemblies to promote their accumulation in 
the perinuclear StiF.
DISCUSSION
The Hsp70/90 cochaperone, Sti1, suppresses proteotoxicity by or-
ganizing amyloid-like assemblies into the StiF. The StiF is a juxtanu-
clear compartment containing thioflavin-T–positive assemblies of 
Rnq1 and templated Htt103Q. Amyloid-like protein accumulation in 
the StiF correlates with suppression of proteotoxicity caused by 
Rnq1 and Htt103Q. Partitioning of aberrant proteins between the 
StiF and other protein-handling centers is controlled by interactions 
between Sti1 and the Hsp70 chaperone system. Loss of Sti1 exacer-
bates Htt proteotoxicity, whereas increases in Sti1 levels suppress it 
by increasing protein accumulation in the StiF. Sti1 is identified as a 
component of the Hsp70/Hsp90 system that acts in spatial PQC to 
promote protective protein aggregation.
Sti1 aids in organization of myeloid-like forms of Rnq1 and 
Htt103Q into one or two perinuclear foci (Figure 8). Studies with 
marker proteins show that the StiF exhibits similarities and differ-
ences with respect to the IPOD, JUNQ, and yeast aggresome 
(Kaganovich et al., 2008; Wang et al., 2009; Weisberg et al., 2012). 
Therefore whether the StiF represents a perinuclear IPOD, a JUNQ 
that contains amyloid-like protein, or a novel protein-handling de-
pot is not clear. The aggresome and the IPOD contain detergent-
insoluble and amyloid-like protein species (Kaganovich et al., 2008; 
Wang et al., 2009), whereas the peripheral compartment and JUNQ 
contain detergent-soluble protein aggregates (Kaganovich et al., 
2008; Specht et al., 2011). Therefore Stif could be hybrid protein 
deposition sites formed as a result of cooperation between Hsp70 
and Sti1 in spatial quality control.
Sti1 is a stress-inducible protein, and StiF are most visible when 
Sti1 levels are elevated fivefold to sixfold above normal. Sti1 is in-
duced around threefold in response to heat stress (Supplemental 
Figure S4), so the effect of overexpressed Sti1 on spatial quality 
control of amyloid-like aggregates occurs in a concentration range 
relative to that of endogenous Sti1. Spatial organization of Htt103Q 
is also affected by deletion of STI1, and so endogenous Sti1, as well 
as overexpressed Sti1, affects spatial organization of foci that con-
tain amyloid-like proteins. There is also potential for Sti1 to aid in 
cell stress protection by affecting the spatial organization of amy-
loid-like aggregates that form in response to proteotoxic growth 
conditions.
Why is accumulation of Htt103Q or [RNQ+] prions in the StiF 
cytoprotective? Onset of [RNQ+] prion or Htt103Q toxicity is de-
tected within 4 h of expression (Douglas et al., 2008, 2009), and at 
this time they appear in the cytosol as speckled punctae and diffuse 
assemblies. Elevation of Sti1 accelerates the sequestration of amy-
loid-like proteins into the StiF and increases levels of detergent-in-
soluble oligomers of [RNQ+] and Htt103Q more than twofold. This 
may occur via diversion of amyloidogenic proteins away from the 
IPOD to limit shearing by Hsp104, which could prevent formation 
of toxic oligomers (Chernoff et al., 1995; Tyedmers et al., 2010b). 
Alternatively, Hsp70 functions via a molecular switch mechanism to 
activate Hsp104 (Lee et al., 2013). Thus elevation of Sti1 could hin-
der Hsp70’s ability to activate Hsp104 and thereby increase pools of 
benign amyloid-like protein aggregates.
pole body (Wang et al., 2009) and may serve as a detoxification 
center for amyloid-like proteins.
Sti1 reorganizes complexes that contain Htt103Q 
and Hsp70
Sti1 associates with oligomeric forms of Htt103Q (Figure 2) and co-
localizes with amyloid-like proteins in the StiF (Figure 4), which might 
enable it to suppress Htt toxicity by acting alone or in concert with 
Hsp70/Hsp90. The cochaperone function of Sti1 is conferred by 
three TPR repeats, which are important for interaction with Hsp70 
and Hsp90 (Figure 6A). TPR1 is implicated in interaction with Hsp70, 
and TPR2a with Hsp90, whereas both chaperones bind with lower 
affinity to the TPR2b region (Hernandez et al., 2002; Song and 
Masison, 2005; Flom et al., 2007). Point mutations in TPR1 and 
Tpr2a the hinder Sti1’s ability to regulate Hsp70 and Hsp90 function, 
respectively (Song and Masison, 2005; Flom et al., 2007). Such 
mutants were used to evaluate whether Sti1 interacts with Hsp70 or 
Hsp90 to modulate spatial quality control of Htt103Q toxicity (Figure 
6B). Although mutations in TPR2a and TPR2b had no effect (Figure 
6, B–D), mutations in TPR1 hindered the ability of Sti1 to reorganize 
Htt103Q to the StiF (Figure 6D). TPR1 mutants also lost their ability 
to suppress growth defects caused by Htt103Q (Figure 6B). Thus 
StiF formation and suppression of Htt103Q toxicity require func-
tional domains of Sti1 that enable it to interact with the Hsp70 
system.
To determine the effect of Sti1 on interactions between Hsp70 
and Hsp90 with Htt103Q, we evaluated complex formation be-
tween these proteins by coimmunoprecipitation (Figure 6, E and F). 
Htt103Q was immunoprecipitated from yeast lysates prepared un-
der nondenaturing conditions, and the presence of Ssa1, Hsp90, 
Ydj1, Sis1, and Sse1 in precipitates was determined by Western 
blot. Entrance of Sti1 into complexes altered relative quantities of 
different molecular chaperones that associated with Htt103Q (Figure 
6, E and F). The influence of Sti1 on Hsp70/Hsp90 interactions with 
Htt103Q was sensitive to changes in ATP levels, so its effects are 
specific for the nucleotide bound state of the chaperones (Figure 
6E). Of interest, Sti1 increased levels of Htt103Q that associated 
with the type II Hsp40, Sis1, by around fourfold and Ssa1 by more 
than twofold (Figure 6, E and F). In contrast, little of the type I Hsp40, 
Ydj1, was present, and Sti1 reduced the amount of coprecipitated 
Hsp90 and Sse1. These collective data indicate that spatial quality 
control of amyloid-like assemblies involves Sti1-dependent reorga-
nization of complexes containing Hsp70 and Htt103Q, with the 
greatest effect being a dramatic increase in the presence of Sis1.
Sti1 and Sis1 cooperate to modulate amyloid toxicity
Sis1 interacts with oligomeric forms of Rnq1 to facilitate the propa-
gation and affect the spatial organization of [RNQ+] prions 
(Sondheimer et al., 2001; Aron et al., 2007; Douglas et al., 2009). 
Thus Sti1 and Sis1 may cooperate to suppress growth defects 
caused by the presence of amyloid-like protein in the cytosol. We 
therefore investigated whether Sti1 is required for Sis1 to suppress 
Rnq1 and Htt103Q toxicity (Figure 7, A and B). Elevation of Sis1 di-
minished Rnq1 toxicity in a wild-type strain, but its protective effect 
was severely diminished in a ΔSti1 strain, even though deletion of 
STI1 had no effect on Sis1 expression (Figure 7A). Similarly, elevated 
Sis1 also suppressed the growth defect caused by Htt103Q, and this 
protective effect was reduced in a ΔSti1 strain (Figure 7B).
Further support for functional interaction between Sti1 and Sis1 
in buffering the toxicity of amyloid-like proteins comes from the 
demonstration that Sti1 drives the redistribution of Sis1 to the StiF 
(Figure 7C). Under normal conditions, Rnq1-mRFP was found in 
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in the JUNQ is cytotoxic, as it inhibits normal PQC function 
(Kaganovich et al., 2008; Weisberg et al., 2012; Shiber et al., 2013; 
Summers et al., 2013), and thus diverting these proteins to the StiF 
would also ensure normal function of the ubiquitin proteasome 
[RNQ+] prions sequester Spc42 away from its normal function in 
the spindle pole body, leading to cell death (Treusch and Lindquist, 
2012), so increasing accumulation of [RNQ+] prions to the StiF 
would be protective. Accumulation of amyloid-like protein species 
FIGURE 6: Sti1 reorganizes complexes that contain Htt103Q and Hsp70. (A) Diagram of Sti1’s domain structure. 
(B) Effect of mutating different Sti1 TPR domains on ability to suppress Htt103Q growth defect as monitored by cell 
growth assay plated in fivefold dilutions. (C) Sti1 and Htt103Q expression as monitored by Western blot analysis of 
strains shown in B. (D) Effect of select Sti1 point mutations on Sti1’s ability to reorganize Htt103Q. (E) Effect of elevated 
Sti1 on the multichaperone:substrate complex as monitored by coimmunoprecipitation of Htt103Q and Western blot of 
indicated chaperones. Coimmunoprecipitations were carried out in the absence or presence of ATP as indicated above 
each group of images. (F) Quantitation of chaperones that coimmunoprecipitated with Htt103Q in E. (values represent 
means ± SE, n ≥ 3, *p < 0.05, **p < 0.005). Experiments were carried out in the wild-type Htt103Q integration strain.
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system. The fate of proteins that enter the foci induced by Sti1 is not 
entirely clear, yet these assemblies are highly stable, so Stif may 
serve as a long-term storage vault for otherwise toxic proteins. Thus 
the StiF may function as an IPOD-like perinuclear deposition site for 
amyloid-like proteins.
How does modulation of Sti1 alter spatial partitioning of amy-
loid-like aggregates? Sti1 promotes association of Ssa1 and Sis1 
with Htt103Q while reducing the presence of Hsp90. Sti1’s coopera-
tion with Sis1 in spatial distribution of amyloid-like proteins is consis-
tent with observations that Sis1 affects the subcellular localization of 
prions and misfolded proteins (Douglas et al., 2009; Malinovska 
et al., 2012). During heat stress, Sis1 is proposed to interact with the 
aggregate sorting factor Btn2, targeting misfolded proteins to a jux-
tanuclear location (Malinovska et al., 2012). Sis1 function is also im-
plicated in targeting of [RNQ+] prions to the nucleus (Douglas et al., 
2008, 2009) in a process that may involve Cur1 (Malinovska et al., 
2012). Levels of Btn2 and Cur1 during heat stress are believed to 
regulate the relative cytosolic concentrations of Sis1, thereby dictat-
ing whether misfolded protein accumulates with Sis1 at a juxtanu-
clear site or with Hsp42 at a peripheral cytosolic site (Malinovska 
et al., 2012). Thus there are protein-sorting factors that interact with 
Sis1 and affect targeting of protein aggregates to different protein-
handling centers. Cur1, Btn2, and Hsp42 were deleted from strains 
expressing Htt103Q but were dispensable for Sti1-dependent ac-
cumulation of Htt103Q in the StiF and suppression of Htt toxicity 
(Supplemental Figure S3). Nevertheless, the existence of such spa-
tial PQC factors suggests the possibility that Sti1 and Sis1 function 
in an alternate spatial quality control process for amyloid-like 
proteins.
How might Sti1 reorganize the subcellular foci that contain the 
amyloid-like oligomers with which it interacts? Hsp104 functionally 
interacts with Ssa1, Sis1, and Sti1 in maintenance of the yeast prion 
[PSI+] (Kryndushkin et al., 2002; Reidy and Masison, 2010), as evi-
denced by the observation that deletion of STI1 inhibits the ability 
of overexpressed Hsp104 to eliminate [PSI+] (Reidy and Masison, 
2010). In addition, Sti1 can directly interact with Hsp104, likely 
through its TPR1 domain (Abbas-Terki et al., 2001). Of interest, both 
the elevation of Sti1 and inhibition of Hsp104 for a short period with 
GndHCl prevent accumulation of speckled Rnq1-mRFP foci. Yet 
GndHCl promotes formation of foci in a peripheral location and Sti1 
in a perinuclear location, with Sti1 being dominant over GndHCl. 
Inhibition of Hsp104 eliminates [RNQ+] prions from cells (Sond-
heimer and Lindquist, 2000), but Sti1 overexpression does not cure 
yeast of [RNQ+] prions (Supplemental Figure S4A, left). However, 
when Hsp104 is inhibited, Sti1 elevation accelerates the rate of 
[RNQ+] prion curing caused by inhibition of Hsp104 (Supplemental 
Figure S4). Thus Sti1 does not appear to be an inhibitor of Hsp104. 
Instead, it appears to interact with Sis1 and possibly other spatial 
PQC factors to direct amyloid-like proteins to the StiF, and this se-
questers pools of Rnq1 and Htt103Q away from the machinery that 
would normally break them into smaller speckled foci.
The cochaperones CHIP and BAG3 target Hsp70 clients for deg-
radation via the ubiquitin proteasome or autophagy, respectively 
(Cyr et al., 1994; Meacham et al., 2001; Gamerdinger et al., 2011). 
Sti1 is now reported to enable Hsp70 to function in spatial PQC by 
FIGURE 7: Sti1 and Sis1 cooperate to regulate Rnq1 and Htt103Q 
toxicity. (A, B) Inability of Sis1 to suppress growth defect of 
(A) Rnq1-mRFP (p423-CUP1 plasmid) or (B) Htt103Q (toxic integration 
strain) in a Sti1 deletion strain as monitored by cell growth assay 
plated in fivefold dilutions. Expression levels of Sti1, Sis1, and 
Htt103Q or Rnq1 were measured by Western blot analysis. (C) Effect 
of elevated Sti1 on subcellular localization of Sis1 during Rnq1-mRFP 
expression. Experiments were carried out in a strain in which Sis1 was 
tagged at the endogenous locus with GFP.
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Htt25Q and Htt103Q integration strains were generated using 
the pRS305 plasmid backbone. This vector carried a construct con-
taining an amino-terminal FLAG tag, the first 17 amino acids of Htt, 
a 25- or 103-polyQ stretch, and a carboxy-terminal GFP tag. The Htt 
constructs were integrated under control of a galactose-inducible 
promoter (GAL1). Htt103Q-NoTox was an integration strain that 
lacked a growth defect and thus was used to demonstrate that dele-
tion of STI1 elevates Htt103Q toxicity. The toxic Htt103Q integra-
tion strain was used in every other instance in the article where 
Htt103Q was expressed, except in Figure 1D. Deletion strains for 
Sti1, Hsp42, Cur1, and Btn2 were generated in the toxic Htt103Q 
integration strain and the Htt25Q integration strain by inserting a 
G418 resistance cassette at the genomic locus. This cassette was 
amplified from genomic DNA isolated from the BY4742 deletion li-
brary (YKO Collection; Open Biosystems, Huntsville, AL). Each dele-
tion was verified by PCR from genomic DNA. Sti1 and Hsp42 dele-
tions were further verified by Western blot, but Cur1 and Btn2 were 
not, as no antibody for these proteins was available. A deletion 
strain for Sti1 was also generated in the same manner in the W303 
strain.
Expression of Htt103Q
Htt cultures were grown in synthetic media containing 2% glucose 
until cultures reached a density of 4 OD600 or greater. They were 
then diluted back in 2% raffinose, allowed to recover to mid–log 
phase growth, and finally induced for indicated times with 2% galac-
tose. Except during time courses, Htt25Q and Htt103Q were in-
duced for 4 h. The only exception to these expression conditions 
was when we used the Htt103Q-Pro construct. This construct lacked 
the N terminal FLAG tag and contained a proline-rich region follow-
ing the polyQ stretch. Expression of Htt103Q-Pro was induced with 
2% galactose for 24 h from a low-copy plasmid and galactose-
inducible promoter.
targeting amyloid-like proteins to the StiF. Sti1 is stress inducible, 
and, in humans, CHIP and Sti1 differentially bind to Hsp70 and 
Hsp90 based on changes in phosphorylation (Muller et al., 2013). 
Thus, under normal and stress conditions, subtle changes in Sti1 
levels or phosphorylation status could affect targeting of Hsp70 cli-
ents to an alternate fate. Sti1 is differentially expressed in various 
brain regions of both healthy humans and neurodegenerative dis-
ease patients (Hawrylycz et al., 2012; Martins-de-Souza et al., 2012). 
Thus differences in Sti1 activity in different tissues or cell types 
could affect the efficiency of mammalian spatial PQC, influencing 
the onset of protein conformational disorders. In the future, it will be 
interesting to determine whether differences in the cellular set point 
of spatial quality control factors in healthy and diseased tissues cor-
relate with neuronal subpopulations in which neurodegenerative 
diseases originate.
MATERIALS AND METHODS
Strains and plasmids
Yeast strains and plasmids are listed in Supplemental Tables S1 and 
S2 (Douglas et al., 2008, 2009). All strains harbored Rnq1 in its 
[RNQ+] prion form unless otherwise indicated. The generation of 
isogenic [rnq-] strains was accomplished via sequential passage of 
cells on plates containing 3 mM guanidinium-HCl. Strains were 
transformed with plasmids and cultured in synthetic media as de-
scribed previously (Douglas et al., 2008). Constructs containing a 
copper-inducible promoter (CUP1) were induced at a low constitu-
tive level from basal levels of copper in media unless it is specified 
that media were supplemented with additional CuSO4. This is the 
case for all Rnq1-mRFP microscopy unless otherwise indicated. For 
Sti1-overexpression experiments, Sti1 was always expressed from its 
endogenous promoter on a high-copy plasmid. Each of the Sti1 
point mutants in Figure 6 was created using site-directed mutagen-
esis of the parent yEPlac-Sti1 plasmid and verified by sequencing.
FIGURE 8: Model for chaperone-dependent steps in Sti1-inducible foci formation (StiF). The StiF is perinucear but is not 
localized at the spindle pole body (SPB).
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Immunofluorescence and thioflavin-T staining
Cells were collected and fixed as described. After fixation, sphero-
plasts were generated using 5 mg/ml Zymolyase as to be described 
for size exclusion chromatography. For thioflavin-T staining, sphero-
plasts were treated with 0.1% Triton in PBS for 10 min and then 
washed with sorbitol solution. After this permeabilization, cells were 
incubated with 0.001% thioflavin-T for 10 min, washed, and resus-
pended in sorbitol solution. For immunofluorescence, spheroplasts 
were applied to Teflon-coated glass slides (Electron Microscopy Sci-
ences, Hatfield, PA) with poly-l-lysine–coated wells. Then wells were 
then blocked using buffer containing 0.1 M KPO4, pH 7.5, 0.5% bo-
vine serum albumin, and 0.02% Tween-20. Primary and secondary 
antibodies were applied with washes after each. Antibody incuba-
tion and washes all were carried out with the same blocking buffer.
SDD–AGE
SDD–AGE was carried out as described previously (Douglas et al., 
2008). Briefly, samples were prepared via bead breaking as de-
scribed and normalized by a protein determination assay (DC pro-
tein assay kit; Bio-Rad, Hercules, CA). Equivalent amounts of total 
protein were loaded on a 1.4% agarose gel containing 0.1% SDS, 
run at 90–100 V for approximately 2 h, and then transferred to poly-
vinylidene fluoride at 12 V for 15 h.
Size exclusion chromatography
Nondenaturing extracts from the Htt103Q strain were prepared via 
spheroplasting as follows. Approximately 150 OD of mid–log phase 
cells were resuspended in 2 ml of Z buffer containing 50 mM Tris-Cl, 
pH 7.5, 10 mM MgCl2, 1 M sorbitol, and 30 mM dithiothreitol (DTT) 
and then incubated at room temperature for 15 min. Sample was 
then centrifuged and resuspended in 1 ml of Z buffer with 5 mg of 
Zymolyase added (30 mM DTT) and incubated at 30°C in shaker at 
50 rpm for 45 min. After Zymolyase treatment, spheroplasts were 
centrifuged and carefully washed twice with 1 ml of cold Z buffer 
(1 mM DTT) and then thoroughly resuspend with 800 μl of lysis buf-
fer (listed previously, without Triton) using a cold glass disposable 
pipet. Samples were precleared to remove cell debris and normal-
ized so that the same amount of protein was loaded to the column 
each time. A 500-μl loop was loaded into a Sephacryl S200 column, 
and 500-μl fractions were collected. Western blots show every third 
fraction starting slightly before the void volume as determined by 
thyroglobulin.
Coimmunoprecipitation
The Htt103Q strain carried either an empty vector or the YepLac-
Sti1 construct and was induced and lysed via bead breaking as de-
scribed. For experiments in which ATP was present, the lysis buffer 
contained 75 mM Tris, pH 7.4, 150 mM NaCl, 0.1% Triton, 10 mM 
MgCl, and 4 mM ATP. Lysates were incubated with anti–FLAG M2 
affinity gel (Sigma-Aldrich). Htt103Q that was captured was then 
eluted by addition of 0.2 mg/ml FLAG peptide (Sigma-Aldrich) and 
incubation at 37°C for 20 min. After incubation, samples were spun 
at 4000 rpm for 5 min, and supernatant was harvested, combined 
with sample buffer, and loaded on an SDS–PAGE gel along with an 
input sample. In the case of coimmunoprecipitation from column 
fractions, two 500-μl fractions were combined and a small amount 
reserved for an input sample, and the remaining sample was used 
for the immunoprecipitation.
Luciferase refolding assay
Refolding of denatured luciferase by Ssa1 and Sis1 was performed 
as described previously (Lee et al., 2002). Briefly, firefly luciferase 
High-copy screen for toxicity suppressors
An integration strain carrying a galactose-inducible Htt103Q with 
NLS was transformed with a high-copy yeast expression library in 
which the backbone plasmid carried a 5- to 10-kb fragment of DNA 
(Carlson and Botstein, 1982). Cells were plated on galactose to 
induce expression of the Htt103Q-NLS. Transformants that grew 
under these toxic conditions were verified by 5-fluoroorotic acid 
(5-FOA) screening to be plasmid-dependent suppressors. Suppres-
sor plasmids were rescued from transformants that grew upon ga-
lactose initially but not after passage on 5-FOA. Each full-length 
screen hit also was found to suppress toxicity of the Htt103Q inte-
gration strain used in this study. The screen hit containing Sti1 came 
up twice in the screen. Other genes within the same DNA fragments 
of these two hits were YOR029W and CIN5. Although we subcloned 
each gene with the 5′ and 3′ untranslated regions (from this and the 
other screen hits), we also asked various sources for readily available 
constructs to expedite the verification process. Sti1 was one of these 
genes.
Toxicity assays
Yeast samples were normalized to the same OD600 and then fivefold 
serially diluted in a sterile 96-well plate. Each dilution was plated in 
10-μl spots on appropriate synthetic dropout media. Most images 
of yeast grown on glucose were scanned at 48 h and galactose at 
72 h. Lysates for Western blots from toxicity assays were prepared 
using cultures picked from control growth plates after they were 
scanned. Rnq1 toxicity was assessed on plates containing 2% glu-
cose with 500 μM CuSO4, and Htt toxicity plates contained 2% 
galactose.
SDS–PAGE and Western blotting
Lysates were prepared from pellets of yeast by either mechanical 
disruption via glass bead breaking (for semidenaturing detergent 
agarose gel electrophoresis [SDD–AGE] and coimmunoprecipita-
tion) as described previously (Douglas et al., 2008, 2009) or an 
alkali lysis method as described previously (Summers et al., 2013; 
for samples that were directly run on SDS–PAGE gels). For 
mechanical disruption, the lysis buffer used was 0.1% Triton X-100, 
75 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM phenyl-
methylsulfonyl fluoride, and Sigma-Aldrich (St. Louis, MO) pro-
tease inhibitor cocktail. Standard separation techniques were used 
to analyze lysates via SDS–PAGE. Protein was transferred to nitro-
cellulose for 75–90 min at 110 V and probed using the indicated 
antibodies. Antibodies used in this study are listed in Supplemen-
tal Table S3 (Lee et al., 2002). The Sti1 antibody was raised in rab-
bit against purified full-length Sti1 protein. The antisera were not 
purified or concentrated any further, as the Western blot signal 
was strong and clean.
Fluorescence microscopy
Fluorescence microscopy was carried out as described previously 
(Douglas et al., 2009). Briefly, cultures were fixed with 4% formalde-
hyde and 0.1 M KPO4, pH 7.4, and stored in 0.1 M KPO4, pH 7.4, 
with 1.2 M sorbitol. When 4′,6-diamidino-2-phenylindole (DAPI) 
stained, cells were permeabilized with 0.1% Triton in phosphate-
buffered saline (PBS), washed twice with PBS, incubated with 
0.5 μg/ml DAPI for 10 min, washed twice again with PBS, and resus-
pended in the sorbitol solution. An Olympus IX81 motorized in-
verted fluorescence microscope (Olympus, Tokyo, Japan) paired 
with MetaMorph software (Molecular Devices, Sunnyvale, CA) was 
used to collect images. Micrographs were merged and processed 
using ImageJ (National Institutes of Health, Bethesda, MD).
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Supplemental Legends 
Supplemental Figure 1. Sti1 specifically alters Htt103Q-GFP spatial and temporal foci 
formation. (A) Sgt2 does not suppress the Htt103Q growth defect as monitored by cell 
growth assay plated in fivefold dilutions.  The toxicity assay was plated on synthetic 
media containing 500uM CuSO4 to induce Sgt2 expression. (B) Impact of Sti1 upon 
Htt103Q-GFP foci formation over time.  Live images were captured at the indicated 
times after galactose induction of Htt103Q-GFP. (C) Stability of Htt103Q-GFP foci during 
Sti1 overexpression as monitored by cycloheximide decay.  After 4 h of Htt103Q-GFP 
induction, cells were treated with cycloheximide, then fixed and imaged at the indicated 
times. Nuclei were visualized using DAPI staining. (D and E) Influence of (D) CHIP or (E) 
Sti1 upon Ssa1 and Sis1 chaperone activity as measured by in vitro luciferase activity 
assay.  Chaperones were added at the indicated concentrations to GndHCl treated 
luciferase and luminescence was measured as a readout for chaperone mediated 
refolding. 
 
Supplemental Figure 2.  Sti1 is not required for Rnq1-NLS relocalization of Htt103Q to 
the nucleus. (A) Lack of Sti1 dependence for Rnq1-mRFP-NLS to target Htt103Q-GFP 
to the nucleus.  Rnq1 was tagged with the SV40 NLS signal and expressed at low levels 
from the CUP1 promoter as in other Rnq1-mRFP localization studies.  Samples 
expressed either Rnq1-mRFP-NLS, Htt103Q-GFP, or both as indicated. (B) Impact of 
Sti1 deletion upon foci formation of Htt103Q-GFP containing a proline rich region.  
Nuclei were visualized using DAPI staining.  (C) Sti1 immunoprecipitates with Hsp70 and 
Hsp90.  Analysis of Sti1 and indicated chaperones in complex with Htt103Q in the 
presence and absence of Htt103Q.  Immunoprecipitation was carried out as in Figure 6.  
Sti1 with a C terminal HA tag was overexpressed from a high copy plasmid under control 
of its endogenous promoter. 
 
Supplemental Figure 3. Other cellular sorting factors are not necessary for Sti1’s 
mechanism of action (A) Impact of deletion of indicated proteins upon Sti1’s ability to 
suppress Htt103Q growth defect as monitored by cell growth assay plated in fivefold 
dilutions. (B) Impact of deletion of indicated proteins upon Sti1’s ability to reorganize 
Htt103Q-GFP. Toxicity and fluorescence microscopy assays were carried out as in 
Figure 1. 
 
Supplemental Figure 4. Sti1 attenuates Hsp104 shearing activity in the presence of 
GndHCl  (A) Curing rate of [RNQ+] is increased in the presence of GndHCl when Sti1 is 
overexpressed as indicated by triton solubility assay followed by Western blot.  Since 
[RNQ+] is triton insoluble, we measured the Rnq1 triton solubility from lysates with 
endogenous and overexpressed Sti1 at the indicated generations post GndHCl 
treatment.  Increased Sti1 does not completely inactivate Hsp104 and cure the cells of 
[RNQ+] as indicated in the left panel without GndHCl treatment.  (B) Quantitation of 
curing rate in (A) as measured by ratio of soluble to insoluble Rnq1.  (C) Sti1 levels 
increase during heat shock.  Protein levels of Sti1 were examined by Western blot 
analysis during a shift from 25°C to 37°C for 1hr compared to overexpression of Sti1 
from a high copy plasmid. 




Supplemental Table 1. Yeast Strains
Strain Genotype Source
W303, MAT leu2‐3,112; trp1‐1; can1‐100; ura3‐1; ade2‐1; his3‐11,15 Open Biosystems
Htt25Q, MAT leu2‐3,112; trp1‐1; can1‐100; ura3‐1; ade2‐1; his3‐11,15; LEU2::Htt25Q This study
Htt103Q, MAT leu2‐3,112; trp1‐1; can1‐100; ura3‐1; ade2‐1; his3‐11,15; LEU2::Htt103Q This study
W303 sti1 , MAT leu2‐3,112; trp1‐1; can1‐100; ura3‐1; ade2‐1; his3‐11,15; sti1::KanMX4 This study
Htt25Q  sti1 , MAT leu2‐3,112; trp1‐1; can1‐100; ura3‐1; ade2‐1; his3‐11,15; sti1::KanMX4; LEU2::Htt25Q This study
Htt103Q  sti1 , MAT leu2‐3,112; trp1‐1; can1‐100; ura3‐1; ade2‐1; his3‐11,15; sti1::KanMX4; LEU2::Htt103Q This study
Htt25Q  hsp42 , MAT leu2‐3,112; trp1‐1; can1‐100; ura3‐1; ade2‐1; his3‐11,15; hsp42::KanMX4; LEU2::Htt25Q This study
Htt103Q  hsp42 , MAT leu2‐3,112; trp1‐1; can1‐100; ura3‐1; ade2‐1; his3‐11,15; hsp42::KanMX4; LEU2::Htt103Q This study
Htt25Q  btn2 , MAT leu2‐3,112; trp1‐1; can1‐100; ura3‐1; ade2‐1; his3‐11,15; btn2::KanMX4; LEU2::Htt25Q This study
Htt103Q  btn2 , MAT leu2‐3,112; trp1‐1; can1‐100; ura3‐1; ade2‐1; his3‐11,15; btn2::KanMX4; LEU2::Htt103Q This study
Htt25Q  cur1 , MAT leu2‐3,112; trp1‐1; can1‐100; ura3‐1; ade2‐1; his3‐11,15; cur1::KanMX4; LEU2::Htt25Q This study
Htt103Q  cur1 , MAT leu2‐3,112; trp1‐1; can1‐100; ura3‐1; ade2‐1; his3‐11,15; cur1::KanMX4; LEU2::Htt103Q This study
Sis1GFP BY4741 MAT a; his3Δ; leu2Δ; met15Δ; ura3Δ; SIS1‐GFP∷HIS3 Invitrogen
Hsp42GFP BY4741 MAT a; his3Δ; leu2Δ; met15Δ; ura3Δ; Hsp42‐GFP∷HIS3 Invitrogen
Spc42GFP BY4741 MAT a; his3Δ; leu2Δ; met15Δ; ura3Δ; Spc42‐GFP∷HIS3 Invitrogen
Supplemental Table 2. Plasmids
Plasmid Source
pRS305‐GAL1‐FLAG‐Htt25Q‐GFP This study
pRS305‐GAL1‐FLAG‐Htt103Q‐GFP This study
pRS426‐CUP1‐FLAG‐Htt103Q‐GFP This study
pRS423‐CUP1‐Rnq1‐mRFP This study
pRS315‐CUP1‐Rnq1‐mRFP Douglas et al, 2009
pRS315‐CUP1‐Rnq1‐GFP Douglas et al, 2008
pRS316‐CUP1‐Rnq1‐mRFP‐NLS Douglas et al, 2009
yEPlac‐Sti1 (endogenous promoter) Vitaly Kushnirov
yEPlac‐Sti1 point mutations This study
yEPlac‐Sti1‐mRFP This study
pRS426‐ACT1‐mCitrine‐Luciferase This study
pRS316‐CUP1‐Sgt2 This study
Yep24‐Cns1 Zuehlke et al, 2012
pRS414‐GPD‐Sis1 Douglas et al, 2008
Addgene plasmid 15583:
pRS416‐GAL1‐Htt103Q‐GFP Susan Lindquist
Supplemental Table 3. Antibodies
Antibody Host Source Catalogue number
GFP Mouse Roche 11814460001
Flag Mouse Sigma F3165
RFP Rabbit Rockland 600‐401‐379
Sti1 Rabbit This study
Pgk1 Mouse Molecular Probes A‐6457
Hsp104 Rabbit Stressgen SPA‐1040
Ssa1 Rabbit Lee et al, 2002
Sis1 Rabbit Lee et al, 2002
Ydj1 Rabbit Lee et al, 2002
Hsp42 Rabbit Johanes Buchner
anti‐mouse HRP Goat Thermo 31436
anti‐rabbit HRP Goat Thermo 31461

